The ATTD of DM decreased then increased (linear, P = 0.001; quadratic, P = 0.003) as TIU/mg of complete feed increased in the ...
Why the current system is broken and what local governments, nonprofits, and philanthropists could do to change it.
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...
Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 -- Reported highly ...
Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) ...
Q3 2025 Earnings Call Transcript November 4, 2025 Corcept Therapeutics Incorporated misses on earnings expectations. Reported ...
Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...
News-Medical.Net on MSN
Daily oral medication matches injectable therapies in reducing bad cholesterol
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
Do ultra-processed foods increase type 2 diabetes risk? Explore the link between what we eat and diabetes rates in this ...
Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback